Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Congress. Senate. To amend the Internal Revenue Code of 1986 to expand human clinical trials qualifying for the orphan drug credit, and for other purposes. S. 1341. 107th Cong., 1st sess., Introduced in Senate August 2, 2001. https://www.govinfo.gov/app/details/BILLS-107s1341is.
Congress, Senate (2001, August 2). To amend the Internal Revenue Code of 1986 to expand human clinical trials qualifying for the orphan drug credit, and for other purposes. (S. 1341 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-107s1341is.
United States, Congress, Senate. To amend the Internal Revenue Code of 1986 to expand human clinical trials qualifying for the orphan drug credit, and for other purposes. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-107s1341is. 107th Congress, S. 1341, Introduced in Senate 2 Aug. 2001.
S.1341 - 107th Congress (2001-2002): To amend the Internal Revenue Code of 1986 to expand human clinical trials qualifying for the orphan drug credit, and for other purposes., S.1341, 107th Cong. (2001), https://www.govinfo.gov/app/details/BILLS-107s1341is.